Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 37% ± 24% | |
microglial cell | 6 studies | 26% ± 4% | |
macrophage | 6 studies | 31% ± 13% | |
GABAergic neuron | 5 studies | 41% ± 17% | |
interneuron | 4 studies | 36% ± 18% | |
neuron | 3 studies | 20% ± 4% | |
endothelial cell | 3 studies | 32% ± 7% | |
astrocyte | 3 studies | 25% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 466.67 | 455 / 459 | 99% | 23.77 | 1109 / 1118 |
intestine | 100% | 536.20 | 964 / 966 | 98% | 13.58 | 516 / 527 |
lung | 99% | 468.12 | 574 / 578 | 95% | 9.97 | 1096 / 1155 |
bladder | 100% | 330.29 | 21 / 21 | 93% | 10.25 | 467 / 504 |
esophagus | 98% | 411.62 | 1418 / 1445 | 93% | 12.69 | 171 / 183 |
prostate | 94% | 296.46 | 231 / 245 | 96% | 9.70 | 481 / 502 |
kidney | 93% | 266.04 | 83 / 89 | 97% | 14.37 | 870 / 901 |
skin | 93% | 465.75 | 1687 / 1809 | 96% | 13.58 | 454 / 472 |
uterus | 92% | 258.00 | 156 / 170 | 94% | 10.64 | 431 / 459 |
thymus | 87% | 224.38 | 565 / 653 | 94% | 9.47 | 568 / 605 |
stomach | 65% | 259.32 | 232 / 359 | 98% | 14.41 | 280 / 286 |
pancreas | 61% | 113.63 | 200 / 328 | 96% | 10.22 | 171 / 178 |
adrenal gland | 72% | 148.28 | 185 / 258 | 79% | 5.80 | 182 / 230 |
brain | 50% | 110.82 | 1331 / 2642 | 94% | 9.37 | 664 / 705 |
ovary | 99% | 369.82 | 178 / 180 | 45% | 2.57 | 195 / 430 |
liver | 78% | 211.44 | 177 / 226 | 40% | 2.30 | 161 / 406 |
blood vessel | 100% | 1733.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.55 | 29 / 29 |
spleen | 100% | 686.41 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.74 | 1 / 1 |
peripheral blood | 100% | 1563.65 | 925 / 929 | 0% | 0 | 0 / 0 |
adipose | 99% | 394.80 | 1189 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 10.36 | 44 / 45 |
heart | 83% | 325.41 | 717 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 5.17 | 60 / 80 |
muscle | 10% | 19.81 | 84 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035357 | Biological process | peroxisome proliferator activated receptor signaling pathway |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0097411 | Biological process | hypoxia-inducible factor-1alpha signaling pathway |
GO_0010510 | Biological process | regulation of acetyl-CoA biosynthetic process from pyruvate |
GO_0005730 | Cellular component | nucleolus |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004740 | Molecular function | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | PDK3 |
Protein name | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3) |
Synonyms | PDHK3 |
Description | FUNCTION: Inhibits pyruvate dehydrogenase activity by phosphorylation of the E1 subunit PDHA1, and thereby regulates glucose metabolism and aerobic respiration. Can also phosphorylate PDHA2. Decreases glucose utilization and increases fat metabolism in response to prolonged fasting, and as adaptation to a high-fat diet. Plays a role in glucose homeostasis and in maintaining normal blood glucose levels in function of nutrient levels and under starvation. Plays a role in the generation of reactive oxygen species. . |
Accessions | ENST00000648777.1 [Q15120-1] ENST00000379162.9 [Q15120-1] Q15120 ENST00000568479.2 [Q15120-2] |